Clinical Trial Update: A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis [Phase 4]

View source ↗

Summary

Phase 4 multicenter, randomized, double-dummy trial comparing esomeprazole magnesium 40 mg daily to lansoprazole 30 mg daily for healing of moderate to severe e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis

Drugs mentioned

• Esomeprazole magnesium (esomeprazole magnesium)
• Lansoprazole (Lansoprazole)

Snippet

Sponsor: AstraZeneca | Conditions: Erosive Esophagitis | Phase 4 | Status: COMPLETED